Limitations of the use of the mtp40 fragment as a marker of differentiation between Mycobacterium tuberculosis and M. bovis by Viana-Niero, Cristina & Leao, Sylvia Cardoso
498
Limitations of the use of the mtp40 fragment as a marker
of differentiation between Mycobacterium tuberculosis
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The bacilli that cause tuberculosis (TB) belong
to the Mycobacterium tuberculosis complex, which
is composed of M. tuberculosis, M. bovis subsp.
bovis, M. africanum and M. microti, as well as the
M. bovis BCG strain used for vaccination. It has
been proposed that newly discovered species
should also be included in this complex. These
new species include M. canettii, a variant of M.
tuberculosis found in the Somalia region(1), M. bovis
subsp. caprae, the etiologic agent of TB in goats(2)
and M. pinnipedii, which causes TB in sea lions
and may also infect humans(3).
Studies involving DNA-DNA hybridization and
sequence analysis of the 16S rDNA sequence, the
16S-23S intergenic spacer sequence and the gene
encoding the hsp65 heat shock protein(4) have
shown that this complex, in fact, constitutes a single
species. For reasons essentially related to the
medical and veterinary significance of this group
of bacteria, as well as to its pathogenic power and
the wide spectrum of hosts receptive to each species,
the nomenclature remains unchanged.
Within this complex of bacteria, M. tuberculosis
is the principal pathogen in humans. However,
cases of human TB resulting from infection with
M. africanum and M. canettii have been reported,
mainly in Africa(1). In addition, M. bovis, the
etiologic agent of bovine TB, may also infect
humans and other animals. Studies conducted in
Argentina and England showed that M. bovis is
responsible for 0.4% to 1% of human TB cases(5,6).
According to the Pan American Health
Organization(7), 7000 new cases of TB appear
annually in South America. There are no data
available regarding human cases of TB resulting
from M. bovis infection in Brazil. This species is
naturally resistant to pyrazinamide (PZA), a drug
used in the treatment of TB in humans, which, in
certain cases, makes the differentiation between
species relevant. Such cases include those in which
epidemiological evidence suggests M. bovis
involvement and those in which the patient fails
to respond to treatment regimes that include PZA.
A diagnosis of TB caused by M. tuberculosis or
by M. bovis can be made through analysis of clinical
data and radiological evidence. However,
bacteriological diagnosis is necessary in order to
confirm the diagnosis and identify the species
involved. M. tuberculosis and M. bovis can be
differentiated using phenotyping techniques such
as tests for niacin production and nitrate reductase,
as well as cultures to assess bacterial growth in the
presence of thiophene-2-carboxylic acid hydrazide
and PZA(4). The polymerase chain reaction (PCR)
method has been incorporated into the routine of
many laboratories as a diagnostic alternative due
to its greater speed, sensitivity and specificity. This
technique allows the distinction between M.
tuberculosis and M. bovis to be made through
differential amplification of the pncA and oxyR gene
sequences(8), amplification and analysis of enzymatic
restriction within the gyrB sequence(9), multiple
amplifications (multiplex PCR) of the DR fragment
regions, the insertion sequence 6110 (IS6110) and
the hsp65 gene(10), as well as amplification of the
mtp40 fragment, which is exclusive to M.
tuberculosis and therefore absent from M. bovis(11).
The mtp40 fragment, contained within the plcA
gene sequence, which encodes the phospholipase C
enzyme of M. tuberculosis, has been widely used for
specific diagnosis of M. tuberculosis in (uncultured)
clinical samples(11) and in cultures of isolated strains(12).
The absence of mtp40 from M. bovis has been verified
by various authors, although the claim that mtp40 is
present in all clinically isolated M. tuberculosis strains
has been challenged(13).
In our laboratory, we analyzed the results from
the amplification of the mtp40 fragment in 790 M.
tuberculosis strains isolated at the Rijksinstituut voor
Volksgezondheid en Milieu (RIVM, National Institute
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phenotypic and genotypic markers in the differential
diagnosis between M. tuberculosis and M. bovis.
Cristina Viana-Niero, Sylvia Cardoso Leão.
Department of Microbiology, Immunology and
Parasitology, UNIFESP-EPM
e-mail: cviana@ecb.epm.br
FINANCIAL SUPPORT:FAPESP (grant no. 00/02525-3);
CABBIO-CNPq (grant no. 480382/01-8);
Rede Brasileira de Pesquisa em TB (Rede-TB, Brazilian
Tuberculosis Research Network)/grant no. 62.0055/01-4-
PACDT-Milenio
500
Samper S, Garcia Marin JF, Martin C, Dominguez L, et
al. Allele-specific PCR method based on pncA and oxyR
sequences for distinguishing Mycobacterium bovis
from Mycobacterium tuberculosis: Intraspecific M.
bovis pncA sequence polymorphism. J Clin Microbiol
1998; 36:239-42.
9. Chimara E, Ferrazoli L, Leão SC. Mycobacterium
tuberculosis complex differentiation using gyrB-restriction
fragment length polymorphism (gyrB-RFLP) analysis.
Submetido a Memórias do Instituto Oswaldo Cruz. 2004.
10 . Yeboah-Manu D, Yates MD, Wilson SM. Application of
a Simple Multiplex PCR To Aid in Routine Work of the
Mycobacterium Reference Laboratory. J Clin Microbiol
2001; 39(11): 4166-8.
11 . Del Portillo P, Murillo LA, Patarroyo ME. Amplification
of a species-specific DNA fragment Mycobacterium
tuberculosis and its possible use in diagnosis. J Clin
Microbiol 1991; 29(10):2163-8.
12 . Liébana E, Aranaz A, Francis B, Cousins D. Assessment
of genetic markers for species differentiation within
the Mycobacter ium tuberculosis complex. J Cl in
Microbiol 1996; 34(4):933-8.
13 . Vera-Cabrera L, Hoard ST, Laszlo A, Johnson WM.
Analysis of genetic polymorfism in the phospholipase
region of Mycobacterium tuberculosis. J Clin Microbiol
1997; 35(5):1190-5.
14 . Viana-Niero C, Vincent V. 1999. Étude moléculaire des
bac i l les  de la  tuberculose d ’or ig ine af r ica ine:
Mycobacterium africanum et souches “canetti”. Tese
de mestrado apresentada à Université Paris V et
Université Paris XI.
15 . Viana-Niero C, de Haas PE, van Soolingen D, Leão S C.
Analysis of genetic polymorphisms affecting the four
phosphol ipase C (p lc )  genes in Mycobacter ium
tuberculosis complex clinical isolates. Microbiol 2004;
150:967-78.
